Zimmer Biomet Holdings (ZBH) Tops Q4 EPS by 5c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/19/2026
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Oil slides after China asks Iran to limit Houthi attacks on Saudi oil facilities
- Warren Buffett transitions to Berkshire’s chairman emeritus
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- S&P 500, Nasdaq advance, turning the page on a tumultuous week
- Anthropic and Accenture partner on embedded AI safety evaluation
- Wells Fargo Downgrades Netflix (NFLX) to Underweight on Engagement Risks, 'We see tougher choices ahead'
- Wells Fargo cuts Netflix rating on engagement risk, weak slate
- Is the S&P 500 in an "earnings bubble"? Goldman weighs in
Needham & Company Raised Price Target on Zimmer Biomet Holdings (ZBH) Following Mixed 4Q Results
January 28, 2016 1:25 PM ESTNeedham & Company reiterated a Buy rating on Zimmer Holdings (NYSE: ZBH), and raised the price target to $129.00 (from $127.00), following the company's 4Q earnings report. Revenue was $1.934B, missing consensus estimates of $1.954B. And EPS was $2.09, beating out the consensus of $2.04.
Analyst Mike Matson... More
